Literature DB >> 20564123

Evaluation of trends in the use of intensity-modulated radiotherapy for head and neck cancer from 2000 through 2005: socioeconomic disparity and geographic variation in a large population-based cohort.

B Ashleigh Guadagnolo1, Chih-Chin Liu, Janice N Cormier, Xianglin L Du.   

Abstract

BACKGROUND: The current study was conducted to evaluate trends in utilization of intensity-modulated radiotherapy (IMRT) for head and neck cancer (HNC).
METHODS: Identified were 5487 patients from the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked database with a diagnosis of HNC (aged>or=65 years) between 2000 and 2005, who received any type of radiotherapy (RT). Multivariate logistic regression analyses were performed to assess the influence of patient, tumor, treatment, and sociodemographic characteristics on receipt of IMRT versus conventional radiotherapy techniques.
RESULTS: Overall, 21.3% of patients in the cohort received IMRT as the technique of irradiation. The use of IMRT increased significantly, with 1.3% of patients receiving it in 2000 compared with 46.1% in 2005 (P<.0001 for trend). Patients treated with RT in 2005 were 68 times more likely to receive IMRT than those treated in 2000. There was significant geographic variation observed in use of IMRT, ranging from 11.3% of cases in Kentucky to 40.4% of cases in Hawaii. Patients in the census tracks comprising the lowest quartile for socioeconomic status were 33% less likely to receive IMRT than patients in the highest quartile, even when adjusting for geographic area and year of diagnosis.
CONCLUSIONS: The use of IMRT has rapidly become widespread for the delivery of RT for patients with HNC. However, there was significant geographic variation noted in the utilization of IMRT. Patients in census tracks comprising the lowest socioeconomic quartile were less likely to receive IMRT than their more affluent counterparts. Copyright (c) 2010 American Cancer Society.

Entities:  

Mesh:

Year:  2010        PMID: 20564123     DOI: 10.1002/cncr.25205

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  18 in total

1.  Use of radiation therapy in the last 30 days of life among a large population-based cohort of elderly patients in the United States.

Authors:  B Ashleigh Guadagnolo; Kai-Ping Liao; Linda Elting; Sharon Giordano; Thomas A Buchholz; Ya-Chen Tina Shih
Journal:  J Clin Oncol       Date:  2012-11-19       Impact factor: 44.544

2.  Treatment trends in head and neck cancer: Surveillance, Epidemiology, and End Results (SEER) Patterns of Care analysis.

Authors:  Jennifer A Schlichting; Nitin A Pagedar; Catherine Chioreso; Charles F Lynch; Mary E Charlton
Journal:  Cancer Causes Control       Date:  2019-05-22       Impact factor: 2.506

3.  Intensity-modulated radiation therapy use for the localized treatment of thyroid cancer: Nationwide practice patterns and outcomes.

Authors:  Paolo Goffredo; Timothy J Robinson; Linda M Youngwirth; Sanziana A Roman; Julie A Sosa
Journal:  Endocrine       Date:  2016-03-30       Impact factor: 3.633

4.  Use of stereotactic radiosurgery for brain metastases from non-small cell lung cancer in the United States.

Authors:  Lia M Halasz; Jane C Weeks; Bridget A Neville; Nathan Taback; Rinaa S Punglia
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-10-09       Impact factor: 7.038

5.  Medical Care Cost of Oropharyngeal Cancer among Texas Patients.

Authors:  David R Lairson; Chi-Fang Wu; Wenyaw Chan; Kristina R Dahlstrom; Samantha Tam; Erich M Sturgis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-08-24       Impact factor: 4.254

6.  The Impact of Intensity Modulated Radiation Therapy on Hospitalization Outcomes in the SEER-Medicare Population With Anal Squamous Cell Carcinoma.

Authors:  Erqi L Pollom; Guanying Wang; Jeremy P Harris; Albert C Koong; Eran Bendavid; Jay Bhattacharya; Daniel T Chang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-01-07       Impact factor: 7.038

7.  Reduced feeding tube duration with intensity-modulated radiation therapy for head and neck cancer: A Surveillance, Epidemiology, and End Results-Medicare Analysis.

Authors:  Beth M Beadle; Kai-Ping Liao; Sharon H Giordano; Adam S Garden; Katherine A Hutcheson; Stephen Y Lai; B Ashleigh Guadagnolo
Journal:  Cancer       Date:  2016-09-23       Impact factor: 6.860

8.  Uptake and outcomes of intensity-modulated radiation therapy for uterine cancer.

Authors:  Jason D Wright; Israel Deutsch; Elizabeth T Wilde; Cande V Ananth; Alfred I Neugut; Sharyn N Lewin; Zainab Siddiq; Thomas J Herzog; Dawn L Hershman
Journal:  Gynecol Oncol       Date:  2013-03-13       Impact factor: 5.482

9.  Correlation of Planned Dose to Area Postrema and Dorsal Vagal Complex with Clinical Symptoms of Nausea and Vomiting in Oropharyngeal Cancer (OPC) patients treated with radiation alone using IMRT.

Authors:  Tony J C Wang; Sandra Fontenla; Patrick McCann; Robert J Young; Stephen McNamara; Shyam Rao; James G Mechalakos; Nancy Y Lee
Journal:  J Radiat Oncol       Date:  2013-02-28

10.  Outcomes and patterns of care of patients with locally advanced oropharyngeal carcinoma treated in the early 21st century.

Authors:  Adam S Garden; Merrill S Kies; William H Morrison; Randal S Weber; Steven J Frank; Bonnie S Glisson; Gary B Gunn; Beth M Beadle; K Kian Ang; David I Rosenthal; Erich M Sturgis
Journal:  Radiat Oncol       Date:  2013-01-29       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.